The team at Morgans has been looking over a number of ASX 200 shares once again.
Among its best ideas for May are the blue chip ASX 200 shares listed below. Here’s what you need to know about them:
ResMed Inc (ASX: RMD)
The first ASX 200 share that could be in the buy zone according to Morgans is ResMed. While the broker suspects that supply chain issues could make things volatile in the near term, it remains very positive on the long term.
While we believe the next few quarters will likely be volatile, as Covid-related demand for ventilators continues to slow and core sleep apnoea volumes gradually lift, nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.
Morgans has an add rating and $39.23 price target on ResMed’s shares.
Treasury Wine Estates Ltd (ASX: TWE)
Another ASX 200 share that could be a top option for investors is Treasury Wine. Morgans rates the wine giant highly due to its strong portfolio and its recent restructuring. All in all, it feels this has positioned the company for strong growth over the coming years.
TWE owns much loved iconic wine brands, the jewel in the crown being Penfolds. We rate its management team highly. The company recently reported an impressive 1H22 result despite facing a number of material headwinds. The foundations are now in place for TWE to deliver strong double-digit growth from 2H22 over the next few years. Trading at a material discount to our valuation and other luxury brand owners, TWE is a key pick for us.
Morgans has an add rating and $13.93 price target on Treasury Wine’s shares.
The post Broker names 2 of the ‘best’ blue chip ASX 200 shares to buy now appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
- Hoping to bag the Resmed dividend? Read this
- Guess which ASX 200 shares are defying today’s sell-off to climb higher
- 2 medical tech ASX shares Morgans loves right now
- Broker names the best ASX shares to buy right now
- Leading brokers name 3 ASX shares to buy today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and Treasury Wine Estates Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/xpbkY4o